KFDA to give disadvantages when not presenting bio-equivalent test items.

Published: 2001-07-30 06:57:00
Updated: 2001-07-30 06:57:00
The KFDA intends to give disadvantages to the drug company who declines to carry out the bio-equivalent test for the items the company already applied for the test.

When the drug of high strength with the same dosage form manufactured by the same company completed its bio-equivalent test, the ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.